Get the Stockscreener App
8.29
2.47%
-0.21
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $8.29, with a volume of 9.91M.
It is down -2.47% in the last 24 hours and up +6.15% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$8.50
Open:
$8.26
24h Volume:
9.91M
Relative Volume:
0.67
Market Cap:
$9.73B
Revenue:
$14.33B
Net Income/Loss:
$-3.79B
P/E Ratio:
-2.6151
EPS:
-3.17
Net Cash Flow:
$1.84B
1W Performance:
-6.22%
1M Performance:
+6.15%
6M Performance:
-38.00%
1Y Performance:
-21.27%
1-Day Range:
$8.19
$8.31
1-Week Range:
$8.19
$8.95
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
8.29 | 10.38B | 14.33B | -3.79B | 1.84B | -3.17 |
|
HLN
Haleon Plc Adr
|
11.14 | 48.63B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
162.58 | 72.59B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.84 | 3.27M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.57 | 44.08B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.96 | 19.43B | 16.54B | -1.64B | 749.00M | -1.45 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
VTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:VTRS) - GlobeNewswire Inc.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider
FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Viatris Inc. (VTRS) Securities Fraud Class Action - PR Newswire
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
VTRS IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Viatris Inc. Investors - Bluefield Daily Telegraph
Viatris (NASDAQ: VTRS) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit - TradingView
Viatris' HIV-1 Generic Medicine Gets Backing From European Medicines Agency - marketscreener.com
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
VTRS FRAUD ALERT: Lose Money when Viatris Inc. Stock - GlobeNewswire
Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS - PR Newswire
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Reminds Viatris Inc. Investors of the Pending Class Action Lawsuit with a ... - Eagle-Tribune
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost - GlobeNewswire
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - Morningstar
Viatris to Participate in Upcoming Investor Conferences - PR Newswire
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 3, 2025 to Discuss Your RightsVTRS - Morningstar
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS - GlobeNewswire
Viatris Inc. (VTRS) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 3, 2025 - ACCESS Newswire
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
VTRS LAWSUIT: Lose Money on Viatris Inc.? Contact BFA Law before June 3 Court Deadline - GlobeNewswire
Ex-Dividend Reminder: Evergy, Viatris and Burford Capital - Nasdaq
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel ... - Eagle-Tribune
DEADLINE ALERT for VTRS, CGC, and ECG: The Law Offices of - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming DeadlinesVTRS - PR Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider
DEADLINE APPROACHING: Berger Montague Advises Viatris (VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 - TradingView
Levi & Korsinsky Reminds Viatris Inc. Investors of the - GlobeNewswire
Viatris Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationVTRS - WV News
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Securities Fraud Class Action Filed Against Viatris Inc. (VTRS)Levi & Korsinsky Reminds Investors of June 3, 2025 - Stockhouse
VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Viatris Inc. ... - Bluefield Daily Telegraph
Viatris, Cognizant, GE Healthcare, Netflix: Top foreign stocks that Indian mutual funds bought in April - Moneycontrol
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Securities Class Action Lawsuit Filed Against Viatris Inc. (VTRS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. - GlobeNewswire
VTRS SHAREHOLDER NEWS: Investors of Viatris Inc. Securities - GlobeNewswire
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TradingView
Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead ... - Bluefield Daily Telegraph
Securities Lawsuit Alert: Viatris Inc. (VTRS) InvestorsContact Levi & Korsinsky Before June 3, 2025 - Stockhouse
VTRS Lawsuit Alert! Class Action Lawsuit Against Viatris Inc. - TipRanks
Shareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class ActionVTRS - WV News
Securities Lawsuit Alert: Viatris Inc. (VTRS)Contact Levi & Korsinsky Before June 3, 2025 - ACCESS Newswire
Viatris Inc. stock rises Thursday, outperforms market - MarketWatch
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider
Viatris Inc. Class Action: The Gross Law Firm Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025VTRS - WV News
Insider Buying: Scott Smith Acquires 60,000 Shares of Viatris In - GuruFocus
Chris Davis Increases Stake in Viatris Inc. with Significant Share Acquisition - GuruFocus
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):